• A new entrant to this year’s Economics 21
• Boasts by far the largest amount of antitrust litigation advisory work in 2016, with its experts involved in 86 separate cases.
• The firm’s 2016 track record includes successful advisory work in major mergers and cartel class actions, advising both defendants and government plaintiffs in court.
|Total size of firm||523|
|% of firm specialised||34%|
|Who’s Who Legal: Competition nominees||6|
Analysis Group enters our Economics 21 list for the first time this year, and the firm’s inclusion is well deserved. The group’s numbers put it firmly in the top five of the categories we examine – including the third-most in-depth merger investigations of any group we poll (14), the fifth-most cases in which their clients were under government investigation (14) and by far the largest number of antitrust litigations (86). The 176 antitrust specialists at Analysis Group – the second-most in the Economics 21 – split their time between the various competition law disciplines. The total picture is a firm that is capable of handling almost any matter, staffing it with a team of talent and, in many cases, winning in court or before the agencies. The firm is indeed in the discussion of the best competition economics consultancy in the world.
The firm’s list of successful matters begins with its work for the US Department of Justice in its challenge of the Anthem/Cigna health insurance merger, which the DOJ successfully blocked in February, after the GCR 100 went to press. Analysis Group’s affiliate David Dranove, a professor at Northwestern University, testified multiple times in court on market definition, medical costs, competitive effects and barriers to entry, helping to convince the court that the deal would indeed harm competition. Bruce Deal, a managing principal at the firm, assisted a group of Chinese solar panel defendants in fending off predatory pricing claims in the Solyndra litigation, eventually securing a favourable settlement in the matter. The firm helped to prepare economic evidence for GlaxoSmithKline in the Wellbutrin pay-for-delay litigation, and it advised Toshiba and Mitsubishi Electric in the CRT class action, among other cases.
Antitrust has been a core focus of Analysis Group’s work since our inception in 1981. We integrate industrial organization theory, industry-specific expertise, and the latest quantitative analytical methods to understand the conduct and market dynamics at issue in antitrust litigation and merger investigations. We have demonstrated our expertise in complex assignments related to class certification, antitrust liability, antitrust damages, and the competitive effects of proposed mergers and acquisitions.
Our antitrust work covers a range of industries and markets, including high tech, financial products, manufacturing products, insurance, health care and pharmaceuticals, agriculture, and many others. Over the last decade, we have provided support to internal and external experts in some of the most significant mergers and government competition investigations, including various recent cable TV mergers and challenges to the Anthem-Cigna merger and St. Luke's acquisition of Saltzer Medical Group. We have also been involved in numerous high-profile monopolization cases involving such companies as Microsoft and Intel, as well as some of the largest cartel cases in industries including credit cards, vitamins, TFT-LCD panels, cathode ray tubes, and auto parts. Another area of focus for our recent antitrust work has been in the pharmaceutical industry, where we have been involved in a number of high-profile reverse-payment, product-hopping, and delayed generic entry matters.
In addition to our antitrust and competition work, we provide expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune 500 companies, and government agencies. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional depth of expertise.